CN Mobile Logo


Thyroid Cancer

Thyroid Cancer

A new study is calling for a change in name for certain thyroid tumors. Patients diagnosed with what is currently known as noninvasive encapsulated follicular variant of papillary thyroid carcinoma have a very low risk for recurrence and therefore, researchers have suggested renaming the condition.

Despite a large increase in the diagnosis of thyroid cancer during the last few decades, a new study indicates that thyroid cancer incidence may be leveling off.

Thyroid lesions identified in pediatric patients were often found to have one of the molecular abnormalities commonly seen in adults with thyroid lesions.

Researchers have identified several characteristics of metastatic papillary thyroid cancer shown on preoperative ultrasound—such as node matting—that are associated with extranodal extension, an important prognostic factor linked with this disease.

A retrospective cohort study showed that body mass index and body surface area are predictive of certain behaviors of papillary thyroid carcinoma.

An increased rate of adverse effects is seen in patients with differentiated thyroid cancer who are being treated with the tyrosine kinase inhibitor sorafenib.

The use of a standard yearly physical examination to screen for thyroid cancer among high-risk survivors of childhood and young adult cancers resulted in a negative predictive value of 100% for clinically relevant thyroid cancer and a significant cost savings compared with regular ultrasound screening.


Subscribe to Thyroid Cancer on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.